CAP TODAY/Dako Webinar: Navigating the complexities of PD-L1 testing

Thank you

To access this webinar and recent CAP TODAY webinars, please visit http://www.captodayonline.com/cap-today-hosted-webinars/

Description

Promises and Pitfalls in Lung Cancer
Keith M. Kerr, BSc(Hons), MB ChB, FRCPath, FRCPE

Technical Brief on PD-L1 IHC
Annika Eklund, PhD

Why should you register now for this webinar?
Engage world-renowned experts on the role of PD-L1 and its relevance to immuno-oncology in cancer therapy
Brought to you by: CAP TODAY and Dako
Moderated by: Bob McGonnagle
Presenters: Keith M. Kerr, BSc(Hons), MB ChB, FRCPath, FRCPE
Annika Eklund, PhD

What will this webinar empower you to do?
Comprehend the basics of immunotherapy
Understand the current dynamics of PD-L1 IHC testing
Gain valuable insight into your future role in cancer care
Ask questions of our distinguished presenters

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Dako, An Agilent Technologies Company.

Contributors

Bob McGonnagle

Publisher, CAP TODAY
Keith M. Kerr, BSc(Hons), MB ChB, FRCPath, FRCPE

Consultant Pathologist, Aberdeen Royal Infirmary, UK
Professor of Pulmonary Pathology, Aberdeen University Medical School
International Fellow of College of American Pathologists
Hon. Fellow of Faculty of Pathology, Royal College of Physicians of Ireland
Annika Eklund, PhD

Global Product Manager, Companion Diagnostics at Agilent Technologies
PhD Pharmacology, Linköping University, Sweden, 2001
MSc Molecular Biology, Umeå University, Sweden, 1995